{"data":[{"accessionNo":"0001193125-26-352401","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Voting Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"PureTech Health plc","reportingCik":null,"personType":"CO","sharesOwned":16685013,"percentOfClass":31.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-352401","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Voting Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"PureTech LYT, Inc.","reportingCik":null,"personType":"CO","sharesOwned":16685013,"percentOfClass":31.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-352401","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Voting Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"PureTech Health LLC","reportingCik":null,"personType":"OO","sharesOwned":16685013,"percentOfClass":31.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-333914","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Zohar Daphne","reportingCik":null,"personType":"IN","sharesOwned":5225497,"percentOfClass":9.1,"filedAt":"2026-08-05","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-333719","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"PAUL STEVEN M","reportingCik":null,"personType":"IN","sharesOwned":3516718,"percentOfClass":6.3,"filedAt":"2026-08-05","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic Partners (Lux) SCSp","reportingCik":null,"personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic GenPar, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"GAP Coinvestments III, LLC","reportingCik":null,"personType":"OO","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"GAP Coinvestments IV, LLC","reportingCik":null,"personType":"OO","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"GAP Coinvestments V, LLC","reportingCik":null,"personType":"OO","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic GenPar (Lux) SCSp","reportingCik":null,"personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic (Lux) S.a r.l.","reportingCik":null,"personType":"HC","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic GenPar (Bermuda), L.P.","reportingCik":null,"personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"GAP (Bermuda) L.P.","reportingCik":null,"personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"GAP Coinvestments CDA, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic, L.P.","reportingCik":"0001017645","personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic (SPV) GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic Partners 100, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000950142-26-001350","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-04","reportingPerson":"General Atlantic (SP), L.P.","reportingCik":null,"personType":"PN","sharesOwned":6101582,"percentOfClass":11.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000886982-26-000211","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002042347","issuerName":"SEAPORT THERAPEUTICS, INC.","ticker":"SPTX","cusip":"81221K108","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-05-06","reportingPerson":"THE GOLDMAN SACHS GROUP, INC.","reportingCik":null,"personType":"HC,CO","sharesOwned":2791814,"percentOfClass":5.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0000886982-26-000211","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002042347","issuerName":"SEAPORT THERAPEUTICS, INC.","ticker":"SPTX","cusip":"81221K108","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-05-06","reportingPerson":"GOLDMAN SACHS & CO. LLC","reportingCik":null,"personType":"BD,OO,IA","sharesOwned":2791814,"percentOfClass":5.5,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-209100","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-05-04","reportingPerson":"ARCH Venture Fund XII, L.P.","reportingCik":"0001906837","personType":"PN","sharesOwned":6294951,"percentOfClass":11.9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-209100","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-05-04","reportingPerson":"ARCH Venture Partners XII, L.P.","reportingCik":"0001979765","personType":"PN","sharesOwned":6294951,"percentOfClass":11.9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-209100","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-05-04","reportingPerson":"ARCH Venture Partners XII, LLC","reportingCik":"0001979548","personType":"OO","sharesOwned":6294951,"percentOfClass":11.9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-209100","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-05-04","reportingPerson":"Robert Nelsen","reportingCik":"0001219042","personType":"IN","sharesOwned":6294951,"percentOfClass":11.9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-209100","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-05-04","reportingPerson":"Keith Crandell","reportingCik":"0001219039","personType":"IN","sharesOwned":6294951,"percentOfClass":11.9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-209100","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-05-04","reportingPerson":"Kristina Burow","reportingCik":"0001569248","personType":"IN","sharesOwned":6294951,"percentOfClass":11.9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"},{"accessionNo":"0001193125-26-209100","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002042347","issuerName":"Seaport Therapeutics, Inc.","ticker":"SPTX","cusip":"81221K108","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-05-04","reportingPerson":"Steven Gillis","reportingCik":"0001229592","personType":"IN","sharesOwned":6294951,"percentOfClass":11.9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/sptx"}],"updatedAt":"2026-11-05T14:37:23.468Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/sptx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}